Trump’s Second Term Health Agency Picks: A Controversial Crew Leading Key Federal Organizations
The team selected by President-elect Donald Trump to head federal health agencies during his second term includes notable figures: a retired congressman, a surgeon, and a former talk-show host. Their roles could significantly affect the government’s approach to health care, food safety, and medical research.
Department of Health and Human Services
The nominee for the Department of Health and Human Services is Robert F. Kennedy Jr., known for advocating against vaccines and environmental issues. Critics argue that Trump’s chosen leaders lack experience in managing large organizations but excel at discussing health topics on television.
Centers for Medicare and Medicaid Services
Dr. Mehmet Oz, a well-known TV personality, may lead the Centers for Medicare and Medicaid Services. This agency oversees health care for over 160 million Americans and has a budget of $1.1 trillion. Oz’s views on Medicaid and Medicare have raised questions due to his previous remarks on coverage for weight-loss drugs.
Food and Drug Administration
Dr. Marty Makary, nominated for the FDA, shares Kennedy’s critiques of the agency. He has spoken against the influence of pharmaceutical companies and questioned some COVID-19 safety protocols. Their plans could face obstacles due to stringent FDA regulations.
Centers for Disease Control and Prevention
Dave Weldon, the choice for the CDC, has a history of opposing vaccine mandates and supports reducing the agency’s budget. His past involvement with misinformation regarding vaccines raises concerns about public health priorities.
Surgeon General
Dr. Janette Nesheiwat, named as surgeon general, has largely supported COVID-19 vaccination efforts. However, her exact public health priorities remain unclear.
National Institutes of Health
As of now, Trump has not announced a candidate for the National Institutes of Health, which focuses on medical research. Kennedy has indicated a desire to shift research priorities away from vaccines.
Trump’s health team emphasizes personal media experience over bureaucratic qualifications, indicating a potential shift in health policy that prioritizes televised discourse over established science. This could lead to significant changes in how health and safety are regulated in the U.S.